Business
Middle East and Africa Biosimilars Market Trends Report 2026-2035, Profiles of AbbVie, Amgen, Biocon, Celltrion, Dr. Reddy's, Pfizer, Roche, Samsung, Sandoz, Teva, Viatris
The Middle East and Africa biosimilars market is poised for strong growth due to patent expiries, increased chronic disease prevalence, and supportive regulations. High demand for affordable biologics, especially for oncological and chronic conditions, presents significant market opportunities amidst challenges like high development costs and regulatory complexities. Middle Eastern and African Biosimilars Market Middle Eastern and African Biosimilars Market Dublin, April 17, 2026 (GLOBE NEWSWIRE
About this update from Abbvie Inc.
[{"type":"image","alt":"Company Logo","displaySize":"","headline":null,"caption":"Company Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":36,"url":"https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/LAb6sww2pvOwp1YOuMHMug--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTUw/https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65","width":300,"height":36}},"lazy":false},{"type":"text","content":"The Middle East and Africa biosimilars market is poised for strong growth due to patent expiries, increased chronic disease prevalence, and supportive regulations. High demand for affordable biologics, especially for oncological and chronic conditions, presents significant market opportunities amidst challenges like high development costs and regulatory complexities.","length":369,"tagName":"p"},{"type":"text","content":"Middle Eastern and African Biosimilars Market","length":45,"tagName":"p"},{"type":"image","alt":"Middle Eastern and African Biosimilars Market","displaySize":"","headline":null,"caption":"Middle Eastern and African Biosimilars Market","credit":"GlobeNewswire Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":600,"height":400,"url":"https://media.zenfs.com/en/globenewswire.com/fc5f9c22ef9a74b84e590fe84df15f31"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/0U2jbbbiuwHZkjwJY1ezaQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTY0MA--/https://media.zenfs.com/en/globenewswire.com/fc5f9c22ef9a74b84e590fe84df15f31","width":600,"height":400}}},{"type":"text","content":"Dublin, April 17, 2026 (GLOBE NEWSWIRE) -- The "Middle East and Africa Biosimilars Market: Industry Trends and Global Forecasts - Distribution by Drug Class, Therapeutic Area, Type of Manufacturer, Distribution Channel, Geographical Regions and Leading Players" report has been added to ResearchAndMarkets.com's offering.The Middle East and Africa biosimilars market is estimated to grow from USD 1.15 billion in the current year to USD 5.73 billion by 2035 at a CAGR of 19% during the forecast period, till 2035.","length":530,"tagName":"p"},{"type":"text","content":"The biosimilars market in the Middle East and Africa is currently experiencing rapid growth, fueled by increased healthcare investments, a rising prevalence of chronic d...